WO1989009052A1 - Composition for inhibiting absorption of nucleic acid bases - Google Patents
Composition for inhibiting absorption of nucleic acid bases Download PDFInfo
- Publication number
- WO1989009052A1 WO1989009052A1 PCT/JP1989/000313 JP8900313W WO8909052A1 WO 1989009052 A1 WO1989009052 A1 WO 1989009052A1 JP 8900313 W JP8900313 W JP 8900313W WO 8909052 A1 WO8909052 A1 WO 8909052A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- composition
- absorption
- group
- acid
- suppressing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
Definitions
- carriers such as excipients such as lactose, sucrose, sodium chloride, glucose, urea, starch, calcium carbonate, kaolin, crystalline cellulose, gay acid, water, ethanol Knol, propanol, simple syrup, dextrose, starch, gelatin Solution, canoleboximetinoresenorelose, ceramics, methylcellulose, binders such as potassium phosphate, polyvinylpyrrolidone, dried starch, sodium alginate, powdered can, Mineral powder, sodium hydrogen carbonate, calcium carbonate, polyoxyethylene sorbitan fatty acid esters, sodium lauryl sulfate, monoglyceride stearate, starch, lactose Disintegrating agents such as sucrose, stearin, cocoa butter, hydrogenated oil, etc., quaternary ammonium bases, absorption accelerators such as sodium lauryl sulfate, glycerin, starch, etc.
- excipients such as lactose, sucrose
- test liquid containing hypoxanthine 5MgZ ⁇ (control group) and the test fluid is et to L one Shisuti down 1 5 mgZ 3 ⁇ 4? Plus liquid (experimental group), their respective [8- 14 C ] Hypoxanthine (49.0 mCi / mmol, ) And add them to each rat and give them an oral zonter at a dose of 1 ⁇ ⁇ ⁇ per 100 g of body weight. Orally administered. Then, about 0.5, 30, and 60 minutes after the administration, about 0.5 blood was collected from the tail vein of each group rat, and the plasma was separated.
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
Claims
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DK595989A DK595989A (da) | 1988-03-28 | 1989-11-27 | Blanding til inhibering af absorption af nucleinsyrebaser |
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP7563888 | 1988-03-28 | ||
JP63/75638 | 1988-03-28 | ||
JP63/99844 | 1988-04-21 | ||
JP9984488 | 1988-04-21 | ||
JP1064556A JPH0236120A (ja) | 1988-03-28 | 1989-03-15 | 核酸塩基の吸収抑制相成物 |
JP1/64556 | 1989-03-15 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1989009052A1 true WO1989009052A1 (en) | 1989-10-05 |
Family
ID=27298513
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP1989/000313 WO1989009052A1 (en) | 1988-03-28 | 1989-03-24 | Composition for inhibiting absorption of nucleic acid bases |
Country Status (2)
Country | Link |
---|---|
EP (1) | EP0365683A4 (ja) |
WO (1) | WO1989009052A1 (ja) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2245491A (en) * | 1990-06-25 | 1992-01-08 | Medvet Science Pty Ltd | Inhibition of metabolic oxalate formation |
US7818444B2 (en) | 2004-04-30 | 2010-10-19 | Move Networks, Inc. | Apparatus, system, and method for multi-bitrate content streaming |
-
1989
- 1989-03-24 EP EP19890903794 patent/EP0365683A4/en not_active Ceased
- 1989-03-24 WO PCT/JP1989/000313 patent/WO1989009052A1/ja not_active Application Discontinuation
Non-Patent Citations (6)
Title |
---|
CHEMICAL ABSTRACTS, Vol. 102, No. 7, Abstract No. 102(7):61163b, 1985, (Columbus, Ohio, U.S.A.) AMUBODE, F.O., et al., J. Agric. Sci., 103(3), 497-502 * |
CHEMICAL ABSTRACTS, Vol. 81, No. 23, Abstract No. 81(23):150847t, 1974, (Columbus, Ohio, U.S.A.) KAL'NITSKII, B.D., Byull. Vses. Nauchno-Issled. Inst. Fiziol., Biokhim. Pitan. Skh. Zhivotn., 7(2), 20-2 * |
CHEMICAL ABSTRACTS, Vol. 91, No. 9, Abstract No. 91(9):73452n, 1979, (Columbus, Ohio, U.S.A.) MURAMATSU, T., et al., J. Nutr., 109(6), 1057-62 * |
CHEMICAL ABSTRACTS, Vol. 95, No. 17, Abstract No. 95(17):148998p, 1981 (Columbus, Ohio, U.S.A.) UEDA, H., et al., Nutr. Rep. Int., 24(1), 85-94 * |
CHEMICAL ABSTRACTS, Vol. 95, No. 5, Abstract No. 95(5):41169s, 1981, (Columbus, Ohio, U.S.A.) AGUILAR, F., et al., Bol. Soc. Quim. Peru. 45(3), 256-65 * |
See also references of EP0365683A4 * |
Also Published As
Publication number | Publication date |
---|---|
EP0365683A1 (en) | 1990-05-02 |
EP0365683A4 (en) | 1990-12-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6511800B1 (en) | Methods of treating nitric oxide and cytokine mediated disorders | |
KR100424124B1 (ko) | 동맥경화및황색종의치료 | |
US6180139B1 (en) | Composition and method for treating nonalcoholic steatohepatitis | |
AU2012332154B2 (en) | 3,4-di-substituted pyridine compound, methods of using and compositions comprising the same | |
CN103058944A (zh) | 调节血液尿酸水平的化合物 | |
US5843969A (en) | Protecting agent for organ or tissue | |
JPH0141604B2 (ja) | ||
WO1989009052A1 (en) | Composition for inhibiting absorption of nucleic acid bases | |
KR101715152B1 (ko) | 아실 코에이:콜레스테롤 아실 트란스퍼라제의 저해활성을 갖는 화합물 및 이를 포함하는 심혈관 질환 예방 또는 치료용 조성물 | |
WO2000024397A1 (fr) | Composition de medicament immunomodulateur | |
EP3150208B1 (en) | Theobromine or its derivatives for the treatment or prevention of uric acid renal lithiasis | |
JPH0236120A (ja) | 核酸塩基の吸収抑制相成物 | |
JPH0368845B2 (ja) | ||
IE51738B1 (en) | Deazapurine nucleoside,formulations thereof,and use thereof in therapy | |
EP0485232B1 (en) | Neovascularisation inhibitors | |
JP2839827B2 (ja) | ウレアーゼ阻害剤 | |
US5700803A (en) | Method for reducing infarct size in subjects afflicted with ischemic heart disease | |
JPS59175425A (ja) | 脳卒中予防剤 | |
JPH0741423A (ja) | 動脈硬化症治療剤 | |
JP2003511097A (ja) | 栄養補助剤 | |
WO2021125313A1 (ja) | 縮合ピリミジン化合物を有効成分とする治療剤 | |
JP4426654B2 (ja) | 免疫調節用医薬組成物 | |
JPH01216931A (ja) | 血中尿酸濃度低減用治療剤 | |
JP3441404B2 (ja) | cAMP−PDE阻害剤 | |
US4788200A (en) | Method and composition for treating arteriosclerosis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): DK US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH DE FR GB IT LU NL SE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1989903794 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1989903794 Country of ref document: EP |
|
WWR | Wipo information: refused in national office |
Ref document number: 1989903794 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1989903794 Country of ref document: EP |